Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035425 · ClinicalTrials.gov registry record · Phase 3
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT00035425 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 120 participants.
The verdict
NCT00035425, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
Interventions
- DRUG linezolid
- DRUG vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2001-11 |
| Est. Completion | 2002-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035425
The ClinicalTrials.gov registry entry for NCT00035425 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which linezolid is the first listed.
NCT00035425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035425 about?
NCT00035425 is a clinical study titled "Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection". This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
What is the current status of trial NCT00035425?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2001-11. Estimated completion is 2002-11.
What interventions are being tested in trial NCT00035425?
The interventions under investigation include: linezolid (DRUG), vancomycin (DRUG).
Who is sponsoring clinical trial NCT00035425?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.